Regulation of tumor-stromal fibroblast interactions: Implications in anticancer therapy

Current Medicinal Chemistry

Volumn 15, Issue 29, 2008, Pages 3062-3067

  Kiaris, Hippokratis ^a   Trimis, George ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Fibroblasts; Screening; Stroma

Indexed keywords

CISPLATIN; DOXORUBICIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; ANTINEOPLASTIC AGENT;

CANCER CELL; CANCER THERAPY; CARCINOGENESIS; CELL COMMUNICATION; CELL INTERACTION; FIBROBLAST; GENE MUTATION; GENETIC REGULATION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PARACRINE SIGNALING; REGULATORY MECHANISM; REVIEW; STROMA; STROMA CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; DRUG EFFECT; GENETICS; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; FIBROBLASTS; GENES, P53; HUMANS; NEOPLASMS; STROMAL CELLS;

EID: 60749136913     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708786848596     Document Type: Review

References (35)

1. Konstantinopoulos, P.A.; Vandoros, G.P.; Karamouzis, M.V.; Gkermpesi, M.; Sotiropoulou-Bonikou, G.; Papavassiliou, A.G.: EGF-R is expressed and AP-1 and NF-kappaB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF. Cell Oncol., 2007, 29, 477-82.
2. Vandoros, G.P.; Konstantinopoulos, P.A.; Sotiropoulou-Bonikou, G.; Kominea, A.; Papachristou, G.I.; Karamouzis, M.V.; Gkermpesi, M.; Varakis, I.; Papavassiliou, A.G. PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J. Cancer Res. Clin. Oncol., 2006, 132, 76-84.
3. Elenbaas, B.; Weinberg, R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res., 2001, 264, 169-84.
4. Tlsty, T.D.; Hein, P.W. Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev., 2001, 11, 54-9.
5. Kalluri, R.; Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer, 2006, 6, 392-401.
6. Olumi, A.F.; Grossfeld, G.D.; Hayward, S.W.; Carroll, P.R.; Tlsty,T.D.; Cunha, G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res., 1999, 59, 5002-11.
7. Lynch, C.C.; Matrisian, L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation, 2002, 70, 561-73.
8. Sercu, S.; Zhang, L.; Merregaert, J. The extracellular matrix protein 1: its molecular interaction and implication in tumor progression. Cancer Invest., 2008, 26, 375-84.
9. Wilson, T.J.; Singh, R.K. Proteases as modulators of tumor-stromal interaction: Primary tumors to bone metastases. Biochim. Biophys. Acta, 2008, 1785, 85-95.
10. Lewis, M.P.; Lygoe, K.A.; Nystrom, M.L.; Anderson, W.P.; Speight, P.M.; Marshall, J.F.; Thomas, G.J. Tumour-derived TGFbeta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer, 2004, 90, 822-32.
11. Ao, M.; Franco, O.E.; Park, D.; Raman, D.; Williams, K.; Hayward, S.W. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res., 2007, 67, 4244-53.
12. De Wever, O.; Nguyen, Q.D.; Van Hoorde. L.; Bracke, M.; Bruyneel, E.; Gespach, C.; Mareel, M. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J., 2004, 18, 1016-8.
13. Bhowmick, N.A.; Chytil, A.; Plieth, D.; Gorska, A.E.; Dumont, N.; Shappell, S.; Washington, M.K.; Neilson, E.G.; Moses, H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 2004, 303, 848-51.
14. Kuperwasser, C.; Chavarria, T.; Wu, M.; Magrane, G.; Gray, J.W.; Carey, L.; Richardson, A.; Weinberg, R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA, 2004, 101, 4966-71.
15. Qiu, W.; Hu. M.; Sridhar. A.; Opeskin, K.; Fox, S.; Shipitsin, M.; Trivett, M.; Thompson, E.R.; Ramakrishna, M.; Gorringe, K.L.; Polyak, K.; Haviv, I.; Campbell, I.G. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Cancer Cell, 2008, 40 650-5.
16. Kurose, K.; Gilley, K.; Matsumoto, S., Watson, P.H.; Zhou, X.P.; Eng, C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet., 2002, 32, 355-7.
17. Hill, R.; Song, Y.; Cardiff, R.D.; Van Dyke, T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell, 2006, 123, 1001-11.
18. Fukinom, K,; Shen, L.; Matsumoto, S.; Morrison, C.D.; Mutter, G.L.; Eng, C. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res., 2004, 64, 7231-6.
19. Patocs, A.; Zhang, L.; Xu, Y.; Weber, F.; Caldes, T.; Mutter, G.L.; Platzer, P.; Eng, C. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med., 2007, 357, 2543-51.
20. Moinfar, F.; Man, Y.G.; Arnould, L.; Bratthauer, G.L.; Ratschek, M.; Tavassoli, F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res., 2000, 60, 2562-6.
21. Kiaris, H.; Chatzistamou, I.; Trimis, G.; Frangou-Plemmenou, M.; Pafiti, A.; Kalofoutis, A. Evidence for a non-autonomous role of p53 in carcinogenesis. Cancer Res., 2005, 65, 1627-30
22. waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum. Mol. Genet., 2008. In Press. Aug 18. ddn252v1-24.
23. Lafkas, D.; Trimis, G.; Papavassiliou, A.G.; Kiaris, H. p53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int. J. Cancer, 2008, 123, 967-71.
24. Burdelya, L.G.; Komarova, E.A.; Hill, J.E.; Browder, T.; Tararova, N.D.; Mavrakis, L.; DiCorleto, P.E.; Folkman, J.; Gudkov, A.V. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res., 2006, 66, 9356-61.
25. Xue, W.; Zender, L.; Miething, C.; Dickins, A.; Hernando, E.; Krizhanovsky, V.; Cordon-Cardo, C.; Lowe, S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature, 2007, 445, 656-60.
26. Brugarolas, J.; Chandrasekaran, C.; Gordon, J.I.; Beach, D.; Jacks, T.; Hannon, G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 1995, 377, 552-27.
27. Krtolica, A.; Parrinello, S.; Lockett, S.; Desprez, P.Y.; Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA, 2001, 98, 12072-77.
28. Nakagawa, H.; Liyanarachchi, S.; Davuluri, R.V.; Auer, H.; Martin, E.W. Jr,; de la Chapelle, A.; Frankel, W.L. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene, 2004, 23, 7366-77.
29. O'Hayer, K.M.; Counter, C.M. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol., 2006, 407, 637-47.
30. Kranenburg, O.; Gebbink, M.F.; Voest, E.E. Stimulation of angiogenesis by Ras proteins. Biochim. Biophys. Acta, 2004, 1654, 23-37.
31. Harding, H.P.; Calfon, M.; Urano, F.; Novoa, I.; Ron, D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol., 2002, 18, 575-99.
32. Zhang, F.; Hamanaka, R.B.; Bobrovnikova-Marjon, E.; Gordan, J.D.; Dai, M.-S., Lu, H.; Simon, M.C.; Diehl, J.A. Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J. Biol. Chem., 2006, 281, 30036-45.
33. Bi, M.; Naczki, C.; Koritzinsky, M.; Fels, D.; Blais, J.; Hu, N.; Harding, H.; Novoa, I.; Varia, M.; Raleigh, J.; Scheuner, D.; Kaufman, R.J.; Bell, J.; Ron, D.; Wouters, B.G.; Koumenis, C. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J., 2005, 24, 3470-81.
34. Caligaris-Cappio, F.; Bergui. L.; Gregoretti, M.G.; Gaidano, G.; Gaboli, M.; Schena, M.; Zallone, A.Z.; Marchisio, P.C. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood, 1991, 77, 2688-93.
35. Bisping, G.; Leo, R.; Wenning, D.; Dankbar, B.; Padró, T.; Kropff, M.; Scheffold, C.; Kröger, M.; Mesters, R.M.; Berdel, W.E.; Kienast, J. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood, 2003, 101, 2775-83.